News

A preprint study from Yale University researchers examined a condition known as post-vaccination syndrome. The study included 42 individuals with PVS and 22 without. Researchers observed elevated levels of spike proteins in the PVS group for 36 to 709 days because the time that lapsed since the last vaccination varied between participants. It is a…Continue reading Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

This week, an op-ed was published in The Conversation, discussing a lack of transparency regarding the materials used to manufacture tampons and other period products. Studies have shown the presence of endocrine disruptors in period products, including “phthalates, volatile organic compounds, parabens, environmental phenols, fragrance chemicals, dioxins, and dioxin-like compounds,” according to a 2024 study.…Continue reading FDA Says Heavy Metals and Other Contaminants in Menstrual Products Are “Unlikely to Harm”

HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight have…Continue reading RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

The White Coat Waste Project (WCWP) revealed that $10 million has been spent on taxpayer-funded studies that use mice and monkeys for transgender experiments, including surgeries and hormone treatments. Senator Rand Paul released his annual Festivus report of wasteful government spending days before Christmas and included $33.2 million in transgender monkey research. The HighWire reported…Continue reading White Coat Waste Project Uncovers $10 Million in Taxpayer-Funded Transgender Animal Experiments

Bayer continues to face struggles related to its acquisition of Monsanto and the flagship product Roundup, which currently has 67,000 pending cases alleging the herbicide has caused serious health conditions. So far, Bayer has paid out $10 billion to settle cases and has $5.9 billion set aside to resolve the pending cases. Sources told Reuters…Continue reading Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

Pfizer has agreed to pay nearly $60 million to settle a lawsuit involving healthcare fraud by its subsidiary Biohaven before Pfizer acquired the company in 2022. The settlement resolves allegations from March 1, 2020 to September 30, 2022 during which Biohaven paid kickbacks to doctors for prescribing its migraine medication Nurtec ODT. The kickbacks were…Continue reading Pfizer to Pay $60M in Healthcare Fraud Settlement Over Biohaven Kickback Scheme